c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi

Genes and Development

Volumn 14, Issue 3, 2000, Pages 301-312

  Wu, Min ^a   Hemesath, Timothy J ^a,b   Takemoto, Clifford M ^a   Horstmann, Martin A ^a   Wells, Audrey G ^a   Price, E Roydon ^a   Fisher, Daniel Z ^c   Fisher, David E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DECODE GENETICS   (Iceland)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

c Kit; MAPK; Microphthalmia; p90 Rsk; Steel factor; Ubiquitin

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; STEEL FACTOR; STEM CELL FACTOR; TRANSCRIPTION FACTOR; UBIQUITIN;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; MICROPHTHALMIA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CRICETINAE; CYSTEINE ENDOPEPTIDASES; DNA-BINDING PROTEINS; HUMANS; MELANOCYTES; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITOGEN-ACTIVATED PROTEIN KINASES; MULTIENZYME COMPLEXES; MUTATION; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-KIT; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; STEM CELL FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; UBIQUITINS;

MAMMALIA; RODENTIA;

EID: 0034142326     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Andrews, R.G., R.A. Briddell, F.R. Appelbaum, and I.K. McNiece. 1994. Stimulation of hematopoiesis in vivo by stem cell factor. Curr. Opin. Hematol 1: 187-196.
2. Armstrong, J.A. and B.M. Emerson. 1998. Transcription of chromatin: These are complex times. Curr. Opin. Genet. Dev. 8: 165-172.
3. Bentley, N.J., T. Eisen, and C.R. Goding. 1994. Melanocyte-specific expression of the human tyrosinase promoter: Activation by the microphthalmia gene product and role of the initiator. Mol. Cell. Biol. 14: 7996-8006.
4. Berk, A.J. 1999. Activation of RNA polymerase II transcription. Curr. Opin. Cell Biol 11: 330-335.
5. Bertolotto, C., K. Bille, J. Ortonne, and R. Ballotti. 1996. Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: Implication of the microphthalmia gene product. J. Cell Biol. 134: 747-755.
6. Bertolotto, C., P. Abbe, T.J. Hemesath, K. Bille, D.E. Fisher, J.P. Ortonne, and R. Ballotti. 1998a. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J. Cell Biol. 142: 827-835.
7. Bertolotto, C., R. Busca, P. Abbe, K. Bille, E. Aberdam, J.P. Ortonne, and R. Ballotti. 1998b. Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: Pivotal role of M boxes (GTCAT-GTGCT) and of microphthalmia. Mol. Cell. Biol. 18: 694-702.
8. Blenis, J. 1993. Signal transduction via the MAP kinases: Proceed at your own RSK. Proc. Natl. Acad. Sci. 90: 5889-5892.
9. Carrel, S. and D. Rimoldi. 1993. Melanoma-associated antigens. Eur. J. Cancer 13: 1903-1907.
10. Chau, V., J.W. Tobias, A. Bachmair, D. Marriott, D.J. Ecker, D.K. Gonda, and A. Varshavsky. 1989. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243: 1576-1583.
11. Chen, R.H., R. Tung, C. Abate, and J. Blenis. 1993. Cytoplasmic to nuclear signal transduction by mitogen-activated protein kinase and 90 kDa ribosomal S6 kinase. Biochem. Soc. Trans. 21: 895-900.
12. Chen, R.H., P.C. Juo, T. Curran, and J. Blenis. 1996. Phosphorylation of c-Fos at the C-terminus enhances its transforming activity. Oncogene 12: 1493-1502.
13. Costa, J., G. Demetri, T. Harrist, A. Dvorak, D. Hayes, E. Merica, D. Menchaca, A. Gringeri, L. Schwartz, and S. Galli. 1996. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J. Exp. Med. 183: 2681-2686.
14. Dalby, K.N., N. Morrice, F.B. Caudwell, J. Avruch, and P. Cohen. 1998. Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J. Biol. Chem. 273: 1496-1505.
15. Dubreuil, P., L. Forrester, R. Rottapel, M. Reedijk, J. Fujita, and A. Bernstein. 1991. The c-fms gene complements the mitogenic defect in mast cells derived from mutant W mice but not mi (microphthalmia] mice. Proc. Natl. Acad. Sci. 88: 2341-2345.
16. Englaro, W., C. Bertolotto, R. Busca, A. Brunet, G. Pages, J.P. Ortonne, and R. Ballotti. 1998. Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. J. Biol. Chem. 273: 9966-9970.
17. Gavin, A.C. and A.R. Nebreda. 1999. A MAP kinase docking site is required for phosphorylation and activation of p90(rsk)/MAPKAP kinase-1. Curr. Biol. 9: 281-284.
18. Ghoda, L., X. Lin, and W.C. Greene. 1997. The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IkappaBalpha and stimulates its degradation in vitro, J. Biol. Chem. 272: 21281-21288.
19. Goldberg, A.L. 1995. Functions of the proteasome: The lysis at the end of the tunnel [Comment]. Science 268: 522-523.
20. Goldberg, A.L. and K.L. Rock. 1992. Proteolysis, proteasomes and antigen presentation. Nature 357: 375-379.
21. Grossman, S.R., M. Perez, A.L. Kung, M. Joseph, C. Mansur, Z.X. Xiao, S. Kumar, P.M. Howley, and D.M. Livingston. 1998. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol. Cell 2: 405-415.
22. Grove, J.R., D.J. Price, P. Banerjee, A. Balasubramanyam, M.F. Ahmad, and J. Avruch. 1993. Regulation of an epitope-tagged recombinant Rsk-1 S6 kinase by phorbol ester and erk/MAP kinase. Biochemistry 32: 7727-7738.
23. Halaban, R., E. Cheng, Y. Zhang, G. Moellmann, D. Hanlon, M. Michalak, V. Setaluri, and D.N. Hebert. 1997. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. Proc. Natl. Acad. Sci. 94: 6210-6215.
24. Hassan, H.T. and A. Zander. 1996. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis. Acta Haematol. 95:257-262.
25. Hemesath, T.J., E. Steingrimsson, G. McGill, M.J. Hansen, J. Vaught, C.A. Hodgkinson, H. Arnheiter, N.G. Copeland, N.A. Jenkins, and D.E. Fisher. 1994. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes & Dev. 8: 2770-2780.
26. Hemesath, T.J., E.R. Price, C. Takemoto, T. Badalian, and D.E. Fisher. 1998. MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature 391: 298-301.
27. Hershko, A. and A. Ciechanover. 1992. The ubiquitin system for protein degradation. Annu. Rev. Biochem. 61: 761-807.
28. Hughes, A.E., V.E. Newton, X.Z. Liu, and A.P. Read. 1994. A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1. Nat. Genet. 7: 509-512.
29. Kaufmann, O., S. Koch, J. Burghardt, H. Audring, and M. Dietel. 1998. Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections. Mod. Pathol. 11: 740-746.
30. Kim, T.K. and T. Maniatis. 1996. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science 273: 1717-1719.
31. King, R., K.N. Weilbaecher, G. McGill, E. Cooley, M. Mihm, and D.E. Fisher. 1999. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for Melanoma diagnosis. Am. J. Pathol. 155: 731-738.
32. Kornberg, R.D. and Y. Lorch. 1999. Chromatin-modifying and -remodeling complexes. Curr. Opin. Genet. Dev. 9: 148-151.
33. Leighton, I.A., K.N. Dalby, F.B. Caudwell, P.T. Cohen, and P. Cohen. 1995. Comparison of the specificities of p70 S6 kinase and MAPKAP kinase-1 identifies a relatively specific substrate for p70 S6 kinase: The N-terminal kinase domain of MAPKAP kinase-1 is essential for peptide phosphorylation. FEBS Lett. 375: 289-293.
34. Lerner, A.B., T. Shiohara, R.E. Boissy, K.A. Jacobson, M.L. Lamoreux, and G.E. Moellmann. 1986. A mouse model for vitiligo. J. Invest. Dermatol. 87: 299-304.
35. Mahaffey, D., Y. Yoo, and M. Rechsteiner. 1993. Ubiquitin metabolism in cycling Xenopus egg extracts. J. Biol. Chem. 268: 21205-21211.
36. Mizushima, S. and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18: 5322.
37. Moore, K.J. 1995. Insight into the microphthalmia gene. Trends Genet. 11: 442-448.
38. Nawaz, Z., D.M. Lonard, A.P. Dennis, C.L. Smith, and B.W. O'Malley. 1999. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. 96: 1858-1862.
39. Palombella, V.J., O.J. Rando, A.L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78: 773-785.
40. Price, E.R., H.F. Ding, T. Badalian, S. Bhattacharya, C. Takemoto, T.P. Yao, T.J. Hemesath, and D.E. Fisher. 1998a. Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microphthalmia. J. Biol. Chem. 273: 17983-17986.
41. Price, E.R., M.A. Horstmann, A.G. Wells, K.N. Weilbaecher, C.M. Takemoto, M.W. Landis, and D.E. Fisher. 1998b. alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J. Biol. Chem. 273: 33042-33047.
42. Roeder, R.G. 1998. Role of general and gene-specific cofactors in the regulation of eukaryotic transcription. Cold Spring Harbor Symp. Quant. Biol. 63: 201-218.
43. Russell, E. 1979. Hereditary anemias of the mouse: A review for geneticists. Adv. Genet. 20: 357-459.
44. Sato, S., K. Roberts, G. Gambino, A. Cook, T. Kouzarides, and C.R. Goding. 1997. CBP/p300 as a co-factor for the Microphthalmia transcription factor. Oncogene 14: 3083-3092.
45. Schouten, G.J., A.C. Vertegaal, S.T. Whiteside, A. Israel, M. Toebes, J.C. Dorsman, A.J. van der Eb, and A. Zantema. 1997. IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J. 16: 3133-3144.
46. Scimeca, J.C., T.T. Nguyen, C. Filloux, and E. Van Obberghen. 1992. Nerve growth factor-induced phosphorylation cascade in PC 12 pheochromocytoma cells. Association of S6 kinase II with the microtubule-associated protein kinase, ERK1. J. Biol. Chem. 267: 17369-17374.
47. Silvers, W.K. 1979. The coat colors of mice: A model for mammalian gene action and interaction. Spinger-Verlag, New York, NY.
48. Sturgill, T.W., L.B. Ray, E. Erikson, and J.L. Maller. 1988. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334: 715-718.
49. Sykora, K.W., J. Tomeczkowski, and A. Reiter. 1997. C-kit receptors in childhood malignant lymphoblastic cells. Leuk. Lymphoma 25: 201-216.
50. Tachibana, M. 1997. Evidence to suggest that expression of MITF induces melanocyte differentiation and haploinsufficiency of MITF causes Waardenburg syndrome type 2A. Pigment Cell Res. 10: 25-33.
51. Tachibana, M., L.A. Perez-Jurado, A. Nakayama, C.A. Hodgkinson, X. Li, M. Schneider, T. Miki, J. Fex, U. Francke, and H. Arnheiter. 1994. Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14.1-p12.3. Hum. Mol. Genet. 3: 553-557.
52. Tassabehji, M., V.E. Newton, and A.P. Read. 1994. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat. Genet. 8: 251-255.
53. Tsai, M., R.H. Chen, S.Y. Tam, J. Blenis, and S.J. Galli. 1993. Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon RI: Rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells. Eur. J. Immunol. 23: 3286-3291.
54. Tsujimura, T., E. Morii, M. Nozaki, K. Hashimoto, Y. Moriyama, K. Takebayashi, T. Kondo, Y. Kanakura, and Y. Kitamura. 1996. Involvement of transcription factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice. Blood 88: 1225-1233.
55. Weilbaecher, K.N., C.L. Hershey, C.M. Takemoto, M.A. Horstmann, T.J. Hemesath, A.H. Tashjian, and D.E. Fisher. 1998. Age-resolving osteopetrosis: A rat model implicating microphthalmia and the related transcription factor TFE3. J. Exp. Med. 187: 775-785.
56. Williams, D.E., J. Eisenman, A. Baird, C. Rauch, K. Van Ness, C.J. March, L.S. Park, U. Martin, D.Y. Mochizuki, H.S. Boswell, G.S. Burgess, D. Cosman, and S.D. Lyman. 1990. Identification of a ligand for the c-kit proto-oncogene. Cell 63: 167-174.
57. Witte, O.N. 1990. Steel locus defines new multipotent growth factor. Cell 63: 5-6.
58. Yasumoto, K., K. Yokoyama, K. Shibata, Y. Tomita, and S. Shibahara. 1994. Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene. Mol. Cell. Biol. 14: 8058-8070.
59. Zakut, R., R. Perlis, S. Eliyahu, Y. Yarden, D. Givol, S.D. Lyman, and R. Halaban. 1993. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells. Oncogene 8: 2221-2229.
60. Zaman, Z., A.Z. Ansari, L. Gaudreau, J. Nevado, and M. Ptashne. 1998. Gene transcription by recruitment. Cold Spring Harbor Symp. Quant. Biol. 63: 167-171.